Metabolomics Reveals Broad-Scale Metabolic Perturbations in Hyperglycemic Mothers During Pregnancy

OBJECTIVE To characterize metabolites across the range of maternal glucose by comparing metabolomic profiles of mothers with high and low fasting plasma glucose (FPG). RESEARCH DESIGN AND METHODS We compared fasting serum from an oral glucose tolerance test at ∼28 weeks’ gestation from 67 Northern European ancestry mothers from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study with high (>90th percentile) FPG with 50 mothers with low (<10th percentile) FPG but comparable BMI. Metabolic data from biochemical analyses of conventional clinical metabolites, targeted mass spectrometry (MS)-based measurement of amino acids, and nontargeted gas chromatography/MS were subjected to per-metabolite analyses and collective pathway analyses using Unipathway annotation. RESULTS High-FPG mothers had a metabolic profile consistent with insulin resistance including higher triglycerides, 3-hydroxybutyrate, and amino acids including alanine, proline, and branched-chain amino acids (false discovery rate [FDR]-adjusted P < 0.05). Lower 1,5-anhydroglucitol in high-FPG mothers suggested recent hyperglycemic excursions (FDR-adjusted P < 0.05). Pathway analyses indicated differences in amino acid degradation pathways for the two groups (FDR-adjusted P < 0.05), consistent with population-based findings in nonpregnant populations. Exploratory analyses with newborn outcomes indicated positive associations for maternal triglycerides with neonatal sum of skinfolds and cord C-peptide and a negative association between maternal glycine and cord C-peptide (P < 0.05). CONCLUSIONS Metabolomics reveals perturbations in metabolism of major macronutrients and amino acid degradation pathways in high- versus low-FPG mothers.

[1]  D. Coustan,et al.  Gestational diabetes mellitus. , 2013, Clinical chemistry.

[2]  J. Skupień,et al.  1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus , 2013, Diabetologia.

[3]  Kåre I. Birkeland,et al.  Metabolic Changes in Urine during and after Pregnancy in a Large, Multiethnic Population-Based Cohort Study of Gestational Diabetes , 2012, PloS one.

[4]  Jussi Paananen,et al.  Hyperglycemia and a Common Variant of GCKR Are Associated With the Levels of Eight Amino Acids in 9,369 Finnish Men , 2012, Diabetes.

[5]  Tuija Tammelin,et al.  Metabolic Signatures of Insulin Resistance in 7,098 Young Adults , 2012, Diabetes.

[6]  C. Newgard Interplay between lipids and branched-chain amino acids in development of insulin resistance. , 2012, Cell metabolism.

[7]  Kirill Veselkov,et al.  UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers. , 2012, Molecular bioSystems.

[8]  Byung-wan Lee,et al.  The Roles of Glycated Albumin as Intermediate Glycation Index and Pathogenic Protein , 2012, Diabetes & metabolism journal.

[9]  A. Dyer,et al.  The Hyperglycemia and Adverse Pregnancy Outcome Study , 2012, Diabetes Care.

[10]  Anne Morgat,et al.  UniPathway: a resource for the exploration and annotation of metabolic pathways , 2011, Nucleic Acids Res..

[11]  Alan,et al.  The Hyperglycemia and Adverse Pregnancy Outcome Study Associations of GDM and obesity with pregnancy outcomes , 2012 .

[12]  J. Calviño,et al.  Insulin resistance and the metabolism of branched-chain amino acids in humans , 2011, Amino Acids.

[13]  Bryan C. Batch,et al.  Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss , 2012, Diabetologia.

[14]  António S. Barros,et al.  Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma. , 2011, Journal of proteome research.

[15]  Svati H Shah,et al.  Differential Metabolic Impact of Gastric Bypass Surgery Versus Dietary Intervention in Obese Diabetic Subjects Despite Identical Weight Loss , 2011, Science Translational Medicine.

[16]  S. Carr,et al.  Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. , 2011, The Journal of clinical investigation.

[17]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[18]  A. Dyer,et al.  Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group , 2008 .

[19]  Oliver Fiehn,et al.  Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women , 2010, PloS one.

[20]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[21]  Egon L. Willighagen,et al.  The Chemical Translation Service—a web-based tool to improve standardization of metabolomic reports , 2010, Bioinform..

[22]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[23]  Bengt Persson,et al.  International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.

[24]  S. Amini,et al.  Estimates of Insulin Sensitivity Using Glucose and C-Peptide From the Hyperglycemia and Adverse Pregnancy Outcome Glucose Tolerance Test , 2009, Diabetes Care.

[25]  O. Fiehn,et al.  FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.

[26]  Sigridur Sia Jonsdottir,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[27]  D. Hadden,et al.  Normal and abnormal maternal metabolism during pregnancy. , 2009, Seminars in fetal & neonatal medicine.

[28]  L. Svetkey,et al.  The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain. , 2009, Omics : a journal of integrative biology.

[29]  A. Dyer,et al.  Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study , 2008, Diabetes.

[30]  S. Kjos,et al.  Maternal Lipids as Strong Determinants of Fetal Environment and Growth in Pregnancies With Gestational Diabetes Mellitus , 2008, Diabetes Care.

[31]  J. Goldstein,et al.  Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.

[32]  S. Hauguel-de Mouzon,et al.  The Human Placenta in Gestational Diabetes Mellitus , 2007, Diabetes Care.

[33]  G. Pardi,et al.  Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. , 2005, American journal of obstetrics and gynecology.

[34]  S. Del Prato,et al.  Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[35]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..

[36]  D. Tudehope,et al.  Obesity in pregnancy: data from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study , 2012 .

[37]  S. Kalhan Protein metabolism in pregnancy. , 2000, The American journal of clinical nutrition.

[38]  N. Butte Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. , 2000, The American journal of clinical nutrition.

[39]  S. Stein,et al.  Deconvolution gas chromatography/mass spectrometry of urinary organic acids--potential for pattern recognition and automated identification of metabolic disorders. , 1999, Rapid communications in mass spectrometry : RCM.

[40]  L H Moulton,et al.  A mixture model with detection limits for regression analyses of antibody response to vaccine. , 1995, Biometrics.

[41]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[42]  B. Metzger,et al.  Effects of Gestational Diabetes on Diurnal Profiles of Plasma Glucose, Lipids, and Individual Amino Acids , 1980, Diabetes Care.